erucylphosphocholine Summary

Networked: 1408 relevant articles (81 outcomes, 232 trials/studies) for this Bio-Agent

Key Diseases for which erucylphosphocholine is Relevant

1. Ischemia : 11 outcomes 17 studies in 114 results
   
2. Myocardial Infarction : 8 outcomes 8 studies in 54 results
   
3. Fibrosis (Cirrhosis) : 8 outcomes 3 studies in 22 results
   
4. Neoplasms (Cancer) : 5 outcomes 18 studies in 144 results
   
5. Stroke (Strokes) : 5 outcomes 7 studies in 35 results
   

Drugs Related to erucylphosphocholine

1. Liposomes (Liposome)
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3. Cytokines
4. Paclitaxel (Taxol)
5. Cholesterol
6. Simvastatin (Zocor)
7. Granulocyte Colony-Stimulating Factor (G-CSF)
8. Insulin (Novolin)
9. atorvastatin (Lipitor)
10. MicroRNAs (MicroRNA)

Therapies Related to erucylphosphocholine

1. Transplantation (Transplant Recipients)
2. Stents
3. Drug Therapy (Chemotherapy)
4. Tissue Therapy (Cell Therapy)
5. Radiotherapy